Thelansis

Avascular Necrosis (Osteonecrosis) Market Outlook Thelansis’s “Avascular Necrosis (Osteonecrosis) Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Avascular Necrosis (Osteonecrosis) treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China). Key business questions answered: How can drug development and lifecycle management strategies be optimized across G8 markets (US, EU5, Japan, and China)? How large is the patient population in terms of incidence, prevalence, segments, and those receiving drug treatments? What is the 10-year market outlook for sales and patient share? Which events will have the greatest ...

Avascular Necrosis (Osteonecrosis) Market Outlook Thelansis’s “Avascular Necrosis (Osteonecrosis) Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Avascular Necrosis (Osteonecrosis) treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China). Avascular Necrosis (Osteonecrosis) Overview Avascular necrosis (AVN) of the femoral head is caused by the interruption of blood supply to the bone of the proximal femur. The loss of blood supply can result from both traumatic and non-traumatic causes and leads to cell death (osteonecrosis). Significant necrosis leads to the total collapse of the overlying articular cartilage of the femoral head seconda...

  Avascular necrosis (AVN), also known as osteoradionecrosis, aseptic necrosis, or ischemic bone necrosis, arises from a disruption in the blood supply to the bone, causing bone tissue to deteriorate. Blood, essential for delivering nutrients and oxygen to bones, becomes obstructed (avascular), leading to necrosis of bone tissue. This process weakens the bone and may eventually lead to its collapse. Joint proximity increases the risk of joint surface collapse, resulting in arthritis pain and inflammation. AVN can affect any bone but typically targets the ends (epiphysis) of long bones like the femur, resulting in hip and knee complications. Commonly affected areas include upper arm bones, shoulders, and ankles. While AVN can impact a single bone, it more frequently affects multiple bones concurrently (multifocal AVN). The severity of AVN's impact depends on the location and extent of bone involvement and the bone's ability to regenerate itself. Factors contributing to AVN inc...

  Avascular necrosis (AVN) of the femoral head is caused by the interruption of blood supply to the bone of the proximal femur. The loss of blood supply can result from both traumatic and non-traumatic causes and leads to cell death (osteonecrosis). Significant necrosis leads to the total collapse of the overlying articular cartilage of the femoral head secondary to the underlying necrotic subchondral bone failure. This occurs before revascularization and regeneration of the necrotic bone can occur due to loss of the underlying structural rigidity of the affected bone as osteoclasts resorb it. The end result of this process is early osteoarthritis (OA) of the hip. The patient will often require a total hip replacement as the osteoarthritis progresses. AVN occurs in 15% to 50% of cases of femoral neck and head fractures and 10% to 25% of hip dislocations. Internal fixation is generally preferred in young patients to save the natural femoral head after a fracture. In contrast, in old...